Skip to content

Gammagard From Takeda Pharmaceuticals America, Inc.:1353264 [27-000636]

awarded

National Institutes of Health · 7529

Read the notice at usaspending ↗

Value
$24k
Published
20 Nov 2026
Deadline
—
Type
award
US-MA

Description

GAMMAGARD FROM TAKEDA PHARMACEUTICALS AMERICA, INC.:1353264 [27-000636]

Key facts

Reference
75N98027P00121
Procedure
PURCHASE ORDER
Contract period
… → 30 Sept 2027
Category
DRUGS AND BIOLOGICALS

Awarded suppliers

Supplier location as published: CAMBRIDGE, US

  • The documents — every attachment, with its text extracted and searchable
  • Qualification — the notice scored against your company profile
  • Tracking and alerts — a pipeline for your bids, and the matching notices by email
  • The API and MCP — the same record in your own tools and your AI assistant

Provenance

Source
usaspending
Notice id
CONT_AWD_75N98027P00121_7529_-NONE-_-NONE-
First seen
22 Nov 2026
Last updated
22 Nov 2026

Licence US Government work — public domain (17 U.S.C. § 105) ↗

Source: USAspending.gov, U.S. Department of the Treasury — a U.S. Government work, not subject to copyright in the United States.

View at source ↗GET /api/v1/tenders/acfaab70-6831-4511-9da0-8d92813c2296

The source notice is authoritative — verify deadlines and documents there before bidding.